Convocatoria 2020 del Reto Social 1

Próxima convocatoria IMI - 2

Juan E. Riese PhD MBAPunto Nacional de Contacto – Reto Social 1 H2020 & IMI2Experto Nacional en el Comité de Programa Reto Social 1Oficina de Proyectos EuropeosSubdirección General de Programas Internacionales de Investigación y Relaciones Institucionales

XXIII Reunión de las CCAA con la SG de Programas Internacionales de Investigación

y Relaciones Institucionales del ISCIII

7 prioridades repartidas en 3 áreas

Area 1. Better health and care, economic growth and sustainable health systems(Topics BHC)

1. Personalised medicine

2. Innovative health and care industry

3. Infectious diseases and improving global health

4. Innovative health and care systems – Integration of care

5. Decoding the role of the environment for health and well-being

Area 2. Digital transformation in health and care (Topics DTH)

Area 3. Trusted digital solutions and cybersecurity in health and care (Topics TDS)

Otras acciones EIC: premios, Instrumento PYME, FTI, FET Open

Fuen

te: C

om

isió

n E

uro

pea

/Dre

amst

ime

Prioridad – Better Health and care, economicgrowth and sustainable health systems (I)

1.1. Personalised Medicine

• SC1-BHC-06-2020: Digital diagnostics – developing tools for supportingclinical decisions by integrating various diagnostic data (10-15M€; 3-4projects – total 40M€)

• SC1-HCO-01-2018/19/20: Actions in support of the InternationalConsortium for Personalised Medicine (1-2M€; 2-4 projects – total 4M€)

• SC1-HCO-03-2020: Bridging the divide in health research and innovation –boosting return on investment (1-2M€; 1-2 projects – total 2M€)

• SC1-HCO-14-2020: Sustained collaboration of national and regionalprogrammes in cancer research (1-5M€; 1-5 projects – total 5M€)

• SC1-HCO-16-2020: Sustained collaboration of national and regionalprogrammes in research on brain-related diseases and disorders of thenervous system (1-5M€; 1-5 projects – total 5M€)

• SC1-HCO-17-2020: Coordinating and supporting research on the humanmicrobiome in Europe and beyond (1-2M€; 1-2 projects – total 2M€)

Prioridad – Better Health and care, economicgrowth and sustainable health systems (II)

1.2. Innovative health and care industry

• SC1-BHC-08-2020: New interventions for Non-Communicable Diseases (4-6M€; 14-20 projects – total 80 M€)

• SC1-BHC-11-2020: Advancing the safety assessment of chemicals without the use of animal testing (10-20M€; 3-6 projects – total 60 M€)

• SC1-HCO-18-2020: Developing methodological approaches for improved clinical investigation and evaluation of high-risk medical devices (1-2M€; 1-2 projects –total 2 M€)

• SC1-HCO-19-2020: Reliable and accessible information on cell and gene-based therapies (1-2M€; 1-2 projects – total 2 M€)

1.3 Infectious diseases and improving global health

• SC1-BHC-17-2020: Global Alliance for Chronic Diseases (GACD) - Prevention and/or early diagnosis of cancer (1-3M€; 7-20 projects – total 20 M€)

• SC1-BHC-20A-2020: Pre-commercial procurement (PCP) for integrated care solutions (5-6M€; 4-5 projects – total 25 M€)

• SC1-BHC-20B-2020: Public procurement of innovative solutions (PPI) for diagnostics for infectious diseases (3-5M€; 5-8 projects – total 25 M€ Fu

ente

: Co

mis

ión

Eu

rop

ea

Prioridad – Better Health and care, economicgrowth and sustainable health systems (III)

1.3 Infectious diseases and improving global health (cont.)

• SC1-BHC-33-2020: Addressing low vaccine uptake (2-3M€; 3-4 projects –total 9 M€)

• SC1-BHC-34-2020: New approaches for clinical management and prevention of resistant bacterial infections in high prevalence settings (15M€; 1-2 projects – total 25 M€)

• SC1-BHC-35-2020: Creation of a European wide sustainable network for harmonised large-scale clinical research studies for infectious diseases (25-30M€; 1-2 projects – total 30 M€)

• SC1-HCO-07-2020: to support the Joint Programming Initiative on Antimicrobial resistance (JPIAMR) (1-5M€; 1-2 projects – total 5 M€)

Fuen

te: C

om

isió

n E

uro

pea

Prioridad – Better Health and care, economicgrowth and sustainable health systems (IV)

1.4. Innovative health and care systems - Integration of care

• SC1-BHC-24-2020: Healthcare interventions for the management of the elderly multimorbid patient (4-6M€; 8-12 projects – total 50 M€)

• SC1-BHC-37-2020: Towards the new generation of clinical trials – trials methodology research (4-6M€; 1-2 projects – total 6 M€) Lump sum

• SC1-HCO-20-2020: Coordination of clinical research activities of the European Reference Networks (1-2M€; 1-2 projects – total 2 M€)

1.5 Decoding the role of the environment for health and well-being

• SC1-BHC-29-2020: Innovative actions for improving urban health and wellbeing - addressing environment, climate and socioeconomic factors (4-5 M€; 7-9 projects – total 35 M€)

• SC1-BHC-36-2020: Micro- and nano-plastics in our environment: Understanding exposures and impacts on human health (4-6M€; 4-6 projects – total 25 M€)

Fuen

te: C

om

isió

n E

uro

pea

Prioridad – Better Health and care, economicgrowth and sustainable health systems (y V)

1.6 Contribution to the Call on Digital transformation in Health and Care

• SC1-DTH-12-2020: Use of Real-World Data to advance research on the management of complex chronic conditions (4-6M€; 7-10 projects – total 41 M€)

• SC1-DTH-13-2020: Implementation research for scaling up and transfer of innovative solutions involving digital tools for people-centred care (3-4M€; 5-6 projects – total 20 M€)

• SC1-HCC-10-2020: Towards a Health research and innovation Cloud: Capitalising on data sharing initiatives in health research (2-3M€; 1-2 projects – total 3 M€)

Fuen

te: C

om

isió

n E

uro

pea

Prioridad – Digital transformation in Health and Care

• SC1-DTH-02-2020: Personalised early risk prediction, prevention and intervention based on Artificial Intelligence and Big Data technologies (4-6M€; 5-8 projects – total 32M€)

• SC1-DTH-04-2020: International cooperation in smart living environments for ageing people (2-4M€; 2-4 projects – total 8M€)

• SC1-DTH-06-2020: Accelerating the uptake of computer simulations for testing medicines and medical devices (6-8M€; 4-5 projects – total 32M€)

• SC1-DTH-14-2020: Pre-commercial Procurement for Digital Health and Care Solutions (5-6M€; 1-2 projects – total 10M€) – (Este Topic sustituye al DTH-10 previsto inicialmente)

• SC1-HCC-06-2020: Coordination and Support to better data and secure cross-border digital infrastructures building on European capacities for genomics and personalised medicine (4M€; 1-4 projects – total 4M€)

• SC1-HCC-07-2020: Support for European eHealth Interoperability roadmap for deployment (1-2M€; 1-2 projects – total 2M€)

• SC1-HCC-08-2020: Scaling up innovation for active and healthy ageing (1-2M€; 1-2 projects – total 2M€)

• SC1-HCC-09-2020: Supporting deployment of eHealth in low and lower middle income countries in Africa for better health outcomes (1-2M€; 1-2 projects – total 2 M€)

En todos los topics DTH se exigen indicadores apropiados para la medida del progreso e impacto del proyecto.

Fuen

te: C

om

isió

n E

uro

pea

Prioridad – Trusted Digital Solutions and Cybersecurity in Health and Care

• DT-TDS-04-2020: AI for Genomics and Personalised Medicine (10M€; 3-4 projects –total 35M€)

• DT-TDS-05-2020: AI for Health Imaging (8-10 M€; 3-5 projects – total 35M€) (focused on the most common types of cancer)

Fuen

te: C

om

isió

n E

uro

pea

/PD

F Fi

ller/

Dr

Wae

lHas

san

Presupuesto total para las convocatorias del SC1

• Call SC1 2018: 650,99 M€

• Call SC1 2019: 787,18 M€

• Call SC1 2020: 783,92 M€

0

100

200

300

400

500

600

700

800

900

2018 2019 2020

Tabla de fechas convocatoria 2020 del SC1

Topics Apertura Cierre Observaciones

SC1-BHC-37-2020 04.07.2019 07.04.2020 RIA-LS

SC1-BHC-06/11/17/20A/20B/33/34/35/36 04.07.2019 07.04.2020 RIA

SC1-BHC-8/24/29 04.07.20191st-24.09.20192nd-07.04.2020

RIA

SC1-DTH-12 04.07.2019 07.04.2020 RIA

SC1-DTH-13 04.07.20191st-24.09.20192nd-07.04.2020

RIA

SC1-HCC-10 04.07.2019 07.04.2020 CSA

SC1-HCO-1/3/7/14/16 a 20 04.07.2019 07.04.2020 ERA-NET/CSA

SC1-DTH-2/4/6/14 19.11.2019 22.04.2020 RIA/PCP

SC1-HCC-6 09.07.2019 13.11.2019 CSA

SC1-HCC-7/8/9 19.11.2019 22.04.2020 CSA

SC1-TDS-5 09.07.2019 13.11.2019 RIA

SC1-TDS-4 19.11.2019 22.04.2020 RIA

Fuen

te: C

om

isió

n E

uro

pea

/12

3rf

La Iniciativa de

Medicamentos Innovadores 2

(IMI 2)http://www.imi.europa.eu/

Fuen

te: I

MI

Funcionamiento de la IMI 2

Fuen

te: I

MI

Las convocatorias IMI 2

Fuen

te: I

MI

1. Central repository of digital pathology slidesto support the development of artificialintelligence tools

2. Health Outcomes Observatories – empowerpatients with tools to measure theiroutcomes in a standardised manner creatingtransparency of health outcomes

3. Improving patient access, understanding andadherence to healthcare information: anintegrated digital health information project

4. Establishing international standards in theanalysis of patient reported outcomes andhealth-related quality of life data in cancerclinical trials

5. Accelerating research & development foradvanced therapy medicinal products

6. Supporting the development of chimericantigen receptor T cells

2-stages Topics previstos en las convocatorias 18ª/19ª

¡Provisionales! Comprobar en:https://www.imi.europa.eu/apply-funding/future-topics

Calls Publication Date: 26 June 2019

Stage 1 deadline: 26 September 2019

Stage 2 deadline: 26 March 2020

Call Identifier: H2020-JTI-IMI2-2019-18-two-stage

Type of Actions: Research and Innovation (RIA)

Fuen

te: C

om

isió

n E

uro

pea

Restricted call to maximise impact of IMI2 JUobjectives and scientific priorities

1-stage Topic previsto en las convocatorias 18/19ª

¡Provisional! Comprobar en:https://www.imi.europa.eu/apply-funding/future-topics

Call Publication Date: 26 June 2019

Submission deadline: 26 September 2019

Call Identifier: H2020-JTI-IMI2-2019-19-single-stage

Type of Actions: Research and Innovation (RIA)

Fuen

tes:

Co

mis

ión

Eu

rop

ea/V

idas

enci

lla

Neurodegeneration and other neuroscience priorities

Digital transformation of clinical trial endpoints in pain

Placebo effect in pain

Psychiatric ratings using intermediate stratified markers -2 (PRISM-2)

Immunology

Psoriatic arthritis

Infection control including vaccines

New topic(s) under the AMR accelerator platform

Translational safety

Dosing in specific populations

Big data, digital health, clinical trials and regulatory research

ROADMAP 2: need and opportunity for public-private collaborative research to continue the RoadMap efforts

Facilitating the translation of advanced therapies to patients in Europe

ATMP Patient Registries Outcomes Data and Evidence

Innovative Manufacturing of Advanced Therapeutic Medicinal Products, ATMPs

Other enablers of research topics

Handling of biologic drug products

Potential future IMI Call topics

Last updated April, 2019

Fuen

te: C

om

isió

n E

uro

pea

Las oportunidades en el European Innovation Council (EIC)

Fuen

te: C

om

isió

n E

uro

pea

€1028 millions for 2019€1228 millions for 2020

Más información: https://ec.europa.eu/research/eic/index.cfm?pg=funding

Resumen oportunidades en el European Innovation Council (EIC)

Fuen

te: C

om

isió

n E

uro

pea

Más información: https://ec.europa.eu/research/eic/index.cfm

Información sobre convocatorias en: http://eu-isciii.es